Advertisement
Screener

MOSAIC IMMUNOENGINEERING, INC. (CPMV) Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31)

1.6 / 5 stars · 18/57 Roast Me

MOSAIC IMMUNOENGINEERING, INC. Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31)

MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) of $67.78 thousand for the 3-month period ending 2019-02-28, per its 10-Q filed 2019-04-15.

Discontinued › Income Statement › Other Income

us-gaap:EquityMethodInvestmentSummarizedFinancialInformationCostOfSales · last filed 2019-04-15

  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2019-02-28 was $67.78K, a 24.26% decline year-over-year.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2018-11-30 was $29.49K, a 85.92% decline year-over-year.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2018-08-31 was $29.56K, a 44.87% increase year-over-year.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for the quarter ending 2018-05-31 was $165.16K, a 1906.83% increase year-over-year.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2018 was $484.43K, a 29.64% decline from fiscal 2017.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2017 was $688.53K, a 19.36% decline from fiscal 2016.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2016 was $853.80K, a 48.97% decline from fiscal 2015.
  • MOSAIC IMMUNOENGINEERING, INC. equity method investment, summarized financial information, cost of sales (deprecated 2020-01-31) for fiscal 2015 was $1.67M, a 61.92% decline from fiscal 2014.
Period endEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 3 monthEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 6 monthEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 9 monthEquity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) 12 month
2019-02-28$67.78K
10-Q · filed 2019-04-15
$97.26K
derived: sum of 2 quarters · filed 2019-04-15
$126.82K
10-Q · filed 2019-04-15
$291.99K
derived: sum of 4 quarters · filed 2019-04-15
2018-11-30$29.49K
10-Q · filed 2019-01-14
$59.05K
10-Q · filed 2019-01-14
$224.21K
derived: sum of 3 quarters · filed 2019-01-14
$313.69K
derived: sum of 4 quarters · filed 2019-04-15
2018-08-31$29.56K
10-Q · filed 2018-10-15
$194.72K
derived: sum of 2 quarters · filed 2018-10-15
$284.20K
derived: sum of 3 quarters · filed 2019-04-15
$493.59K
derived: sum of 4 quarters · filed 2019-04-15
2018-05-31$165.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29
$254.65K
derived: sum of 2 quarters · filed 2019-04-15
$464.03K
derived: sum of 3 quarters · filed 2019-04-15
$484.43K
10-K · filed 2018-08-29
2018-02-28$89.48K
10-Q · filed 2019-04-15
$298.87K
derived: sum of 2 quarters · filed 2019-04-15
$319.27K
10-Q · filed 2019-04-15
$327.50K
derived: sum of 4 quarters · filed 2019-04-15
2017-11-30$209.38K
10-Q · filed 2019-01-14
$229.78K
10-Q · filed 2019-01-14
$238.01K
derived: sum of 3 quarters · filed 2019-01-14
$302.29K
derived: sum of 4 quarters · filed 2019-01-14
2017-08-31$20.40K
10-Q · filed 2018-10-15
$28.63K
derived: sum of 2 quarters · filed 2018-10-15
$92.91K
derived: sum of 3 quarters · filed 2018-10-15
$598.35K
derived: sum of 4 quarters · filed 2018-10-15
2017-05-31$8.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29
$72.51K
derived: sum of 2 quarters · filed 2018-08-29
$577.95K
derived: sum of 3 quarters · filed 2018-08-29
$688.53K
10-K · filed 2018-08-29
2017-02-28$64.28K
10-Q · filed 2018-04-16
$569.72K
derived: sum of 2 quarters · filed 2018-04-16
$680.30K
10-Q · filed 2018-04-16
$972.24K
derived: sum of 4 quarters · filed 2018-04-16
2016-11-30$505.44K
10-Q · filed 2018-01-16
$616.02K
10-Q · filed 2018-01-16
$907.96K
derived: sum of 3 quarters · filed 2018-01-16
$1.17M
derived: sum of 4 quarters · filed 2018-01-16
2016-08-31$110.58K
10-Q · filed 2017-10-16
$402.52K
derived: sum of 2 quarters · filed 2017-10-16
$663.63K
derived: sum of 3 quarters · filed 2017-10-16
$558.90K
derived: sum of 4 quarters · filed 2017-10-16
2016-05-31$291.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29
$553.05K
derived: sum of 2 quarters · filed 2017-08-29
$448.32K
derived: sum of 3 quarters · filed 2017-08-29
$853.80K
10-K · filed 2017-08-29
2016-02-29$261.11K
10-Q · filed 2017-04-13
$156.38K
derived: sum of 2 quarters · filed 2017-04-13
$561.86K
10-Q · filed 2017-04-13
$706.18K
derived: sum of 4 quarters · filed 2017-04-13
2015-11-30-$104.73K
10-Q · filed 2017-01-17
$300.75K
10-Q · filed 2017-01-17
$445.07K
derived: sum of 3 quarters · filed 2017-01-17
$1.35M
derived: sum of 4 quarters · filed 2017-01-17
2015-08-31$405.48K
10-Q · filed 2016-10-17
$549.80K
derived: sum of 2 quarters · filed 2016-10-17
$1.45M
derived: sum of 3 quarters · filed 2016-10-17
$1.63M
derived: sum of 4 quarters · filed 2016-10-17
2015-05-31$144.32K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29
$1.05M
derived: sum of 2 quarters · filed 2016-08-29
$1.22M
derived: sum of 3 quarters · filed 2016-08-29
$1.67M
10-K · filed 2016-08-29
2015-02-28$901.37K
10-Q · filed 2016-04-14
$1.08M
derived: sum of 2 quarters · filed 2016-04-14
$1.53M
10-Q · filed 2016-04-14
$2.02M
derived: sum of 4 quarters · filed 2016-04-14
2014-11-30$179.28K
10-Q · filed 2016-01-14
$627.36K
10-Q · filed 2016-01-14
$1.12M
derived: sum of 3 quarters · filed 2016-01-14
$1.18M
derived: sum of 4 quarters · filed 2016-01-14
2014-08-31$448.07K
10-Q · filed 2015-10-15
$939.99K
derived: sum of 2 quarters · filed 2015-10-15
$999.76K
derived: sum of 3 quarters · filed 2015-10-15
$3.18M
derived: sum of 4 quarters · filed 2015-10-15
2014-05-31$491.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31
$551.69K
derived: sum of 2 quarters · filed 2015-08-31
$2.73M
derived: sum of 3 quarters · filed 2015-08-31
$4.39M
10-K · filed 2015-08-31
2014-02-28$59.78K
10-Q · filed 2015-04-14
$2.24M
derived: sum of 2 quarters · filed 2015-04-14
$3.90M
10-Q · filed 2015-04-14
$5.28M
derived: sum of 4 quarters · filed 2015-04-14
2013-11-30$2.18M
10-Q · filed 2015-01-14
$3.84M
10-Q · filed 2015-01-14
$5.22M
derived: sum of 3 quarters · filed 2015-01-14
$7.93M
derived: sum of 4 quarters · filed 2015-01-14
2013-08-31$1.66M
10-Q · filed 2014-10-15
$3.04M
derived: sum of 2 quarters · filed 2014-10-15
$5.74M
derived: sum of 3 quarters · filed 2014-10-15
$7.64M
derived: sum of 4 quarters · filed 2014-10-15
2013-05-31$1.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-19
$4.08M
derived: sum of 2 quarters · filed 2014-08-19
$5.98M
derived: sum of 3 quarters · filed 2014-08-19
$7.55M
10-K · filed 2014-08-19
2013-02-28$2.70M
10-Q · filed 2013-04-15
$4.60M
derived: sum of 2 quarters · filed 2013-04-15
$6.17M
10-Q · filed 2013-04-15
$6.48M
derived: sum of 4 quarters · filed 2013-08-23
2012-11-30$1.90M
10-Q · filed 2013-01-14
$3.46M
10-Q · filed 2013-01-14
$3.78M
derived: sum of 3 quarters · filed 2013-08-23
$6.40M
derived: sum of 4 quarters · filed 2013-08-23
2012-08-31$1.56M
10-Q · filed 2012-10-15
$1.88M
derived: sum of 2 quarters · filed 2013-08-23
$4.50M
derived: sum of 3 quarters · filed 2013-08-23
$6.66M
derived: sum of 4 quarters · filed 2013-08-23
2012-05-31$312.58K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-23
$2.93M
derived: sum of 2 quarters · filed 2013-08-23
$5.10M
derived: sum of 3 quarters · filed 2013-08-23
$7.67M
10-K · filed 2013-08-23
2012-02-29$2.62M
10-Q · filed 2013-04-15
$4.78M
derived: sum of 2 quarters · filed 2013-04-15
$7.36M
10-Q · filed 2013-04-15
2011-11-30$2.16M
10-Q · filed 2013-01-14
$4.74M
10-Q · filed 2013-01-14
2011-08-31$2.58M
10-Q · filed 2012-10-15